as 07-01-2024 4:00pm EST
Cutera Inc is a medical device company. It specializes in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States geographic segment.
Founded: | 1988 | Country: | United States |
Employees: | N/A | City: | BRISBANE |
Market Cap: | 39.7M | IPO Year: | 2004 |
Target Price: | $7.67 | AVG Volume (30 days): | 615.0K |
Analyst Decision: | Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -7.91 | EPS Growth: | N/A |
52 Week Low/High: | $1.28 - $21.41 | Next Earning Date: | 08-06-2024 |
Revenue: | $196,636,000 | Revenue Growth: | -21.00% |
Revenue Growth (this year): | -22.29% | Revenue Growth (next year): | 8.22% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Karavitis Michael | CUTR | EVP, Chief Technology Officer | May 14 '24 | Sell | $2.59 | 24,940 | $64,594.60 | 0 | SEC Form 4 |
Karavitis Michael | CUTR | EVP, Chief Technology Officer | May 14 '24 | Sell | $2.67 | 27,815 | $74,266.05 | 24,940 | SEC Form 4 |
Karavitis Michael | CUTR | EVP, Chief Technology Officer | May 14 '24 | Sell | $2.45 | 10,848 | $26,577.60 | 52,755 | SEC Form 4 |
CUTR Breaking Stock News: Dive into CUTR Ticker-Specific Updates for Smart Investing
Insider Monkey
4 days ago
Business Wire
19 days ago
Business Wire
22 days ago
Business Wire
25 days ago
Business Wire
a month ago
GuruFocus.com
2 months ago
Insider Monkey
2 months ago
Zacks
2 months ago
The information presented on this page, "CUTR Cutera Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.